February 4th is recognized as World Cancer Day, a global initiative led by the Union for International Cancer Control (UICC) that is focused on awareness, education and action. The goal of this day is to create a world where death from cancer is preventable and where everyone can access proper care and life-saving treatment.
2020 was eventful, to say the least. It was a year where many had to shift and pivot from their everyday normal. Appointments were cancelled, surgeries were delayed and rescheduled, and patients found themselves having to access their doctors and healthcare team through a screen. Breast cancer patients had to not only worry about their risk of contracting the COVID-19 virus, but they also had to maintain their cancer care as best they could, something that was a challenge both mentally and physically.
Before I was diagnosed, I rarely thought about breast cancer. When I did it was once a year, usually in June, as I was planning the line-up of pink-ribbon beauty products I wanted to feature in the upcoming October issue of FASHION, Salon, 29Secrets or whatever other magazine I was working for at the time. Other than that, it just wasn’t on my radar. No disease was really. My inner circle was healthy, well, that is if you didn’t count my mom’s dad dying of liver sclerosis from alcoholism when I was around five or my paternal grandmother passing from Alzheimer’s when I was in my early thirties.
Sugar, in all its stark white, sparkling glory is an enormously popular, widely misunderstood, and a hotly debated topic in the breast cancer world. Rarely a week passes when I don’t hear or read “Sugar feeds breast cancer”, proclaimed with absolute certainty. People accept this declaration as truth, yet I ask; does it really?
In part 1 of our clinical trials series, we explained that clinical trials allow doctors and researchers to test treatments, medical procedures and therapies for various diseases and conditions. In the second part of the series, we debunked 7 common myths on clinical trials. In both parts, we focused on the type of clinical trials most people think of when they hear clinical trials, studies involving drugs. However, clinical trials can study more than just drug treatments or surgeries. According to Clinical Trials Ontario, they can also be conducted to “test devices, genetic therapies, natural health products, psychotherapies, lifestyle and preventive care interventions, and many other things.”
Two years ago, I had the sincere pleasure of attending my first oncology nutrition symposium, a biennial event hosted by the Oncology Dietetic Practice Group of the Academy of Nutrition and Dietetics. Nutrition science ruled at this event, and “voodoo nutrition” based on conjecture, personal opinion, philosophies, and miracle cures was denied a seat at the table.
Every year scientists, clinicians and patients from across the world gather to present and discuss the latest breast cancer research at the San Antonio Breast Cancer Symposium. We’ve gathered some highlights from 2019 conference:
CBCN had the opportunity to join researchers, clinicians, manufacturers and other patients at this annual European conference to learn the latest insights and findings in cancer research. Here’s the research that we found most interesting as breast cancer patients:
There’s always interesting research updates released at the American Society of Clinical Oncology Conference – here’s what you need to know.
We’re sharing some interesting research results that we seen in the news recently.
Are you looking for a clinical trial but not sure how to start or where to go? A new Clinical Trials Finder has been developed by Clinical Trials Ontario (CTO) to help you. You can search for a clinical trial in any province or territory in Canada, using only a few simple search terms.
Last month, we had the opportunity to attend the 2018 San Antonio Breast Cancer Symposium (SABCS). Here’s some of the key highlights to come out of the conference.
That’s what Dr. Majumder and her team of researchers at Brandon University in Manitoba are hoping to find out. Dr. Majumder, Assistant Professor in Cancer Genetics and Cell Biology, is screening blood plasma from breast cancer patients and patients who don’t have breast cancer to determine if there is a blood biomarker like micro RNA (miRNA) that could potentially tell us when breast cancer is present or growing in a person.
Earlier this month, the annual meeting for the American Society of Clinical Oncology was held in Chicago. Here, key research developments in every area of cancer care are shared with oncology professionals from around the world. We’ve compiled the top breast cancer highlights to come out of this year’s ASCO 2018 conference:
It’s powerful what happens when patients, caregivers, and clinicians come together to look at research priorities; a broad list of questions that encompasses a variety of viewpoints emerges.
Here are some highlights from the latest in breast cancer research:
Every year clinicians, researchers, patient advocates and industry members head to Texas to share the latest breakthroughs in breast cancer research. It’s a key conference to learn about new treatments or new standards of care for breast cancer patients. Here’s some of the highlights that have the most impact on patient care today:
This year I was honoured to participate as a patient representative on the steering committee of the Canadian Cancer Research Conference hosted by the Canadian Cancer Research Alliance at the beginning of November.